ARNOPTIC
ActiveSummary
The computed 12-month bankruptcy probability of ARNOPTIC is 1.7% (moderate). The 2025 annual accounts show negative equity (-€45,573) and a net result of €34,912. Equity is shrinking by about 21% per year across the filed financial years. Its solvency ranks better than 16% of 22,238 sector peers (NACE 47, financial year 2025). The company has been active since 2019 and the Belgian Official Gazette contains no insolvency or warning signals.
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
27-02
NBB filing
Annual accounts filed
financial year 2025 · micro format · 27 days late
2025
30-06
Financial
Back to profitnet €34,912
Net result €34,912 after 5 loss-making years.
27-02
NBB filing
Annual accounts filed
financial year 2024 · micro format · 27 days late
2024
26-02
NBB filing
Annual accounts filed
financial year 2023 · micro format · 26 days late
2023
28-02
NBB filing
Annual accounts filed
financial year 2022 · micro format · 28 days late
2022
28-02
NBB filing
Annual accounts filed
financial year 2021 · micro format · 28 days late
2021
28-02
NBB filing
Annual accounts filed
financial year 2020 · micro format · 28 days late
Financial milestoneNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
0 of 2 deeds read
About the unread acts
We know of 2 Belgian Official Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.